Browse Title Index
Issue Title
Vol 64, No 5 (2014) Prognostic risk factors of anastomotic leakage following anterior resection in patients with rectal cancer: when is a protective stoma needed? Literature review of 15 457 patients Abstract   PDF (Polish)   HTML (Polish)
Andrzej Rutkowski, Tomasz Olesiński, Leszek Zając
Vol 50, No 6 (2000) Prognostic significance of a single positive result of the RT-PCR tyrosinase assay for cutaneous melanoma patients without distant metastases Details   PDF (Polish)
P. Rutkowski, J. A. Siedlecki, Z. I. Nowecki, J. Kulig, W. Ruka, A. Wilczyńska, Z. Żurawski
Vol 64, No 2 (2014) Prognostic significance of dose intensity and haematological toxicity in breast cancer patients administered with adjuvant CMF chemotherapy Abstract   PDF (Polish)   HTML (Polish)
Ewa Szutowicz, Barbara Radecka, Rafał Dziadziuszko, Jacek Jassem
Vol 72, No 1 (2022) Prognostic significance of sex in patients with primary tracheal tumors – a retrospective, single-center study Abstract   PDF
Aleksandra Piórek, Adam Płużański, Dariusz Mirosław Kowalski, Maciej Krzakowski
Vol 54, No 3 (2004) Prognostic significance of telomerase activity in neuroblastoma like tumours Details   PDF (Polish)
A. Reich, B. Kazanowska, E. Drożyńska, M. Reich, A. Chybicka
Vol 51, No 3 (2001) Prognostic value and importance of surgery combined with postoperative radiotherapy for oral and oropharyngeal cancer Details   PDF (Polish)
A. Maciejewski
Vol 52, No 6 (2002) Prognostic value of selected immunohistochemical markers in skin melanoma Details   PDF (Polish)
W. Kycler, S. Grodecka-Gazdecka, J. Bręborowicz, V. Filas, M. Teresiak
Vol 52, No 6 (2002) Prognostic value of the time interval between surgery and adjuvant radiotherapy in patients treated for early stage invasive cervical cancer Details   PDF (Polish)
R. Krynicki, G. Panek, W. Wierzba, J. Jońska, B. Lindner, K. Gawrychowski, M. Bidziński
Vol 55, No 2 (2005) Prognostic value of thymidylate synthase expression in colorectal cancer Details   PDF (Polish)
A. Patla, J. Pawlęga
Vol 60, No 4 (2010) Program komputerowy StageCRAFT Details   PDF (Polish)
M. Crowe
Vol 57, No 3 (2007) Program mitomycyna, ifosfamid, cisplatyna (MIC) – jego zastosowanie u chorych z niedrobnokomórkowym rakiem płuca w stopniu zaawansowania IIIB i IV Details   PDF (Polish)
R. Ramlau, Ł. Spychalski, J. Kuczek, E. Marcinkowska-Kania
Vol 61, No 1 (2011) Program rozszerzonego dostępu do leku lapatynib w skojarzeniu z kapecytabiną u chorych na raka piersi z nadmierną ekspresją HER2 w stadium miejscowego zaawansowania lub rozsiewu w Polsce Details   PDF (Polish)
T. Pieńkowski, J. Pikiel, A. Jagiełło-Gruszfeld, M. Wojtukiewicz, E. Nowara, J. Załuski, E. Chmielowska, I. Ryniewicz-Zander, J. Krzyżanowska, A. Goszczyński
Vol 68, No 3 (2018) Progress in adjuvant treatment of melanoma patients Abstract   PDF
Piotr Rutkowski, Wojciech M. Wysocki, Tomasz Świtaj, Arkadiusz Jeziorski
Vol 66, No 1 (2016) Progression-free survival as a reliable criterion for assessment of the value of systemic anticancer therapy Abstract   PDF (Polish)   HTML (Polish)
Piotr Rutkowski
Vol 61, No 6 (2011) Promienie X w latach 1896-1897 Details   PDF (Polish)
R. F. Mould
1831 - 1845 of 2875 Items <<   <   118 119 120 121 122 123 124 125 126 127   >   >> 

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl